{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:16:20Z","timestamp":1770884180352,"version":"3.50.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00210-025-04547-4","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T11:37:22Z","timestamp":1756726642000},"page":"2481-2493","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Loss of CD90 alters EMT-associated features and drug sensitivity in U-CH1 chordoma cells"],"prefix":"10.1007","volume":"399","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0776-1238","authenticated-orcid":false,"given":"Didem","family":"Tecimel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6607-5430","authenticated-orcid":false,"given":"Nur Ekimci","family":"G\u00fcrcan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3406-5905","authenticated-orcid":false,"given":"Didem","family":"Seven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Utku","family":"Ozbey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2499-7525","authenticated-orcid":false,"given":"U\u011fur","family":"T\u00fcre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7562-6604","authenticated-orcid":false,"given":"\u00d6mer Faruk","family":"Bayrak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"4547_CR1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abl3674","volume":"8","author":"A Al Shihabi","year":"2022","unstructured":"Al Shihabi A, Davarifar A, Nguyen HTL et al (2022) Personalized chordoma organoids for drug discovery studies. Sci Adv 8:eabl3674. https:\/\/doi.org\/10.1126\/sciadv.abl3674","journal-title":"Sci Adv"},{"key":"4547_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s13256-018-1784-y","volume":"12","author":"O Alan","year":"2018","unstructured":"Alan O, Akin Telli T, Ercelep O et al (2018) Chordoma: a case series and review of the literature. J Med Case Rep 12:239. https:\/\/doi.org\/10.1186\/s13256-018-1784-y","journal-title":"J Med Case Rep"},{"key":"4547_CR3","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.drudis.2021.10.014","volume":"27","author":"VM Alves","year":"2022","unstructured":"Alves VM, Korn D, Pervitsky V et al (2022) Knowledge-based approaches to drug discovery for rare diseases. Drug Discov Today 27:490\u2013502. https:\/\/doi.org\/10.1016\/j.drudis.2021.10.014","journal-title":"Drug Discov Today"},{"key":"4547_CR4","doi-asserted-by":"publisher","first-page":"7360","DOI":"10.1158\/1078-0432.CCR-17-1549","volume":"23","author":"T Avril","year":"2017","unstructured":"Avril T, Etcheverry A, Pineau R et al (2017) CD90 expression controls migration and predicts dasatinib response in glioblastoma. Clin Cancer Res 23:7360\u20137374. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-1549","journal-title":"Clin Cancer Res"},{"key":"4547_CR5","doi-asserted-by":"publisher","first-page":"810","DOI":"10.3171\/2011.12.JNS11430","volume":"116","author":"E Aydemir","year":"2012","unstructured":"Aydemir E, Bayrak OF, Sahin F et al (2012) Characterization of cancer stem-like cells in chordoma: laboratory investigation. JNS 116:810\u2013820. https:\/\/doi.org\/10.3171\/2011.12.JNS11430","journal-title":"JNS"},{"key":"4547_CR6","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.neo.2018.06.001","volume":"20","author":"S Barkeer","year":"2018","unstructured":"Barkeer S, Chugh S, Batra SK, Ponnusamy MP (2018) Glycosylation of cancer stem cells: function in stemness, tumorigenesis, and metastasis. Neoplasia 20:813\u2013825. https:\/\/doi.org\/10.1016\/j.neo.2018.06.001","journal-title":"Neoplasia"},{"key":"4547_CR7","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3171\/2011.7.SPINE10798","volume":"15","author":"OF Bayrak","year":"2011","unstructured":"Bayrak OF, Aydemir E, Gulluoglu S et al (2011) The effects of chemotherapeutic agents on differentiated chordoma cells: laboratory investigation. SPI 15:620\u2013624. https:\/\/doi.org\/10.3171\/2011.7.SPINE10798","journal-title":"SPI"},{"key":"4547_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1330797","volume":"15","author":"A Buczy\u0144ska","year":"2024","unstructured":"Buczy\u0144ska A, Sidorkiewicz I, Kr\u0119towski AJ, Adamska A (2024) Examining the clinical relevance of metformin as an antioxidant intervention. Front Pharmacol 15:1330797. https:\/\/doi.org\/10.3389\/fphar.2024.1330797","journal-title":"Front Pharmacol"},{"key":"4547_CR9","doi-asserted-by":"publisher","DOI":"10.15584\/ejcem.2021.1.3","author":"YD Cak\u0131l","year":"2021","unstructured":"Cak\u0131l YD, Ozunal ZG, Kayal\u0131 DG, Aktas RG (2021) The expression of CD44, CD90 and CD133 in response to cisplatin in hepatocellular cancer cells. Eur J Clin Exp Med. https:\/\/doi.org\/10.15584\/ejcem.2021.1.3","journal-title":"Eur J Clin Exp Med"},{"key":"4547_CR10","doi-asserted-by":"publisher","first-page":"10038","DOI":"10.1200\/jco.2007.25.18_suppl.10038","volume":"25","author":"PG Casali","year":"2007","unstructured":"Casali PG, Stacchiotti S, Grosso F et al (2007) Adding cisplatin (CDDP) to imatinib (IM) re-establishes tumor response following secondary resistance to IM in advanced chordoma. JCO 25:10038\u201310038. https:\/\/doi.org\/10.1200\/jco.2007.25.18_suppl.10038","journal-title":"JCO"},{"key":"4547_CR11","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.3892\/ijo.2016.3691","volume":"49","author":"W-C Chen","year":"2016","unstructured":"Chen W-C, Hsu H-P, Li C-Y et al (2016) Cancer stem cell marker CD90 inhibits ovarian cancer formation via \u03b23 integrin. Int J Oncol 49:1881\u20131889. https:\/\/doi.org\/10.3892\/ijo.2016.3691","journal-title":"Int J Oncol"},{"key":"4547_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15072189","volume":"15","author":"L Chen","year":"2023","unstructured":"Chen L, Chau WY, Yuen HT et al (2023) THY1 (CD90) maintains the adherens junctions in nasopharyngeal carcinoma via inhibition of SRC activation. Cancers (Basel) 15:2189. https:\/\/doi.org\/10.3390\/cancers15072189","journal-title":"Cancers (Basel)"},{"key":"4547_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bbrc.2015.07.118","volume":"465","author":"G Cheng","year":"2015","unstructured":"Cheng G, Lanza-Jacoby S (2015) Metformin decreases growth of pancreatic cancer cells by decreasing reactive oxygen species: role of NOX4. Biochem Biophys Res Commun 465:41\u201346. https:\/\/doi.org\/10.1016\/j.bbrc.2015.07.118","journal-title":"Biochem Biophys Res Commun"},{"key":"4547_CR14","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.canlet.2010.01.013","volume":"293","author":"KB Cho","year":"2010","unstructured":"Cho KB, Cho MK, Lee WY, Kang KW (2010) Overexpression of c-myc induces epithelial mesenchymal transition in mammary epithelial cells. Cancer Lett 293:230\u2013239. https:\/\/doi.org\/10.1016\/j.canlet.2010.01.013","journal-title":"Cancer Lett"},{"key":"4547_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/978-1-4939-1862-1_10","volume":"1239","author":"L Cong","year":"2015","unstructured":"Cong L, Zhang F (2015) Genome engineering using CRISPR-Cas9 system. Methods Mol Biol 1239:197\u2013217. https:\/\/doi.org\/10.1007\/978-1-4939-1862-1_10","journal-title":"Methods Mol Biol"},{"key":"4547_CR16","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00383-007-2033-4","volume":"24","author":"HC Fiegel","year":"2008","unstructured":"Fiegel HC, Kaifi JT, Quaas A et al (2008) Lack of Thy1 (CD90) expression in neuroblastomas is correlated with impaired survival. Pediatr Surg Int 24:101\u2013105. https:\/\/doi.org\/10.1007\/s00383-007-2033-4","journal-title":"Pediatr Surg Int"},{"key":"4547_CR17","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.3727\/096504017X14874349473815","volume":"25","author":"S Gulluoglu","year":"2017","unstructured":"Gulluoglu S, Sahin M, Tuysuz EC et al (2017) Leukemia inhibitory factor promotes aggressiveness of chordoma. Oncol Res 25:1177\u20131188. https:\/\/doi.org\/10.3727\/096504017X14874349473815","journal-title":"Oncol Res"},{"key":"4547_CR18","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s13402-019-00454-y","volume":"42","author":"S Gulluoglu","year":"2019","unstructured":"Gulluoglu S, Tuysuz EC, Sahin M et al (2019) The role of TNF-\u03b1 in chordoma progression and inflammatory pathways. Cell Oncol (Dordr) 42:663\u2013677. https:\/\/doi.org\/10.1007\/s13402-019-00454-y","journal-title":"Cell Oncol (Dordr)"},{"key":"4547_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037159","volume":"7","author":"DWY Ho","year":"2012","unstructured":"Ho DWY, Yang ZF, Yi K et al (2012) Gene expression profiling of liver cancer stem cells by RNA-sequencing. PLoS ONE 7:e37159. https:\/\/doi.org\/10.1371\/journal.pone.0037159","journal-title":"PLoS ONE"},{"key":"4547_CR20","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1002\/ijc.29939","volume":"138","author":"PT Huynh","year":"2016","unstructured":"Huynh PT, Beswick EJ, Coronado YA et al (2016) CD90(+) stromal cells are the major source of IL-6, which supports cancer stem-like cells and inflammation in colorectal cancer. Int J Cancer 138:1971\u20131981. https:\/\/doi.org\/10.1002\/ijc.29939","journal-title":"Int J Cancer"},{"key":"4547_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.adcanc.2022.100055","volume":"5","author":"MS Islam","year":"2022","unstructured":"Islam MS, Morshed MR, Babu G, Khan MA (2022) The role of inflammations and EMT in carcinogenesis. Advances in Cancer Biology - Metastasis 5:100055. https:\/\/doi.org\/10.1016\/j.adcanc.2022.100055","journal-title":"Advances in Cancer Biology - Metastasis"},{"key":"4547_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1089\/cell.2012.0048","volume":"15","author":"Q Jia","year":"2013","unstructured":"Jia Q, Zhang X, Deng T, Gao J (2013) Positive correlation of Oct4 and ABCG2 to chemotherapeutic resistance in CD90+CD133+ liver cancer stem cells. Cell Reprogram 15:143\u2013150. https:\/\/doi.org\/10.1089\/cell.2012.0048","journal-title":"Cell Reprogram"},{"key":"4547_CR23","doi-asserted-by":"publisher","DOI":"10.21769\/bioprotoc.325","volume":"3","author":"S Johnson","year":"2013","unstructured":"Johnson S, Chen H, Lo P-K (2013) In vitro tumorsphere formation assays. Bio-Protoc 3:e325. https:\/\/doi.org\/10.21769\/bioprotoc.325","journal-title":"Bio-Protoc"},{"key":"4547_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.oraloncology.2018.03.004","volume":"80","author":"JP Joseph","year":"2018","unstructured":"Joseph JP, Harishankar MK, Pillai AA, Devi A (2018) Hypoxia induced EMT: a review on the mechanism of tumor progression and metastasis in OSCC. Oral Oncol 80:23\u201332. https:\/\/doi.org\/10.1016\/j.oraloncology.2018.03.004","journal-title":"Oral Oncol"},{"key":"4547_CR25","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.semcdb.2012.03.010","volume":"23","author":"L Kerosuo","year":"2012","unstructured":"Kerosuo L, Bronner-Fraser M (2012) What is bad in cancer is good in the embryo: importance of EMT in neural crest development. Semin Cell Dev Biol 23:320\u2013332. https:\/\/doi.org\/10.1016\/j.semcdb.2012.03.010","journal-title":"Semin Cell Dev Biol"},{"key":"4547_CR26","doi-asserted-by":"publisher","first-page":"11611","DOI":"10.1007\/s13277-016-5112-0","volume":"37","author":"A Kumar","year":"2016","unstructured":"Kumar A, Bhanja A, Bhattacharyya J, Jaganathan BG (2016) Multiple roles of CD90 in cancer. Tumor Biol 37:11611\u201311622. https:\/\/doi.org\/10.1007\/s13277-016-5112-0","journal-title":"Tumor Biol"},{"key":"4547_CR27","doi-asserted-by":"crossref","unstructured":"Larsson LI, Holck S (2014) Extracellular signal-regulated kinases 1 and 2. In: Schwab M (ed) Encyclopedia of cancer. Springer, Berlin, Heidelberg, pp 1\u20136","DOI":"10.1007\/978-3-642-27841-9_2070-2"},{"key":"4547_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0199254","volume":"13","author":"ARM Lobba","year":"2018","unstructured":"Lobba ARM, Carreira ACO, Cerqueira OLD et al (2018) High CD90 (THY-1) expression positively correlates with cell transformation and worse prognosis in basal-like breast cancer tumors. PLoS ONE 13:e0199254. https:\/\/doi.org\/10.1371\/journal.pone.0199254","journal-title":"PLoS ONE"},{"key":"4547_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11060838","volume":"11","author":"N Loret","year":"2019","unstructured":"Loret N, Denys H, Tummers P, Berx G (2019) The role of epithelial-to-mesenchymal plasticity in ovarian cancer progression and therapy resistance. Cancers (Basel) 11:838. https:\/\/doi.org\/10.3390\/cancers11060838","journal-title":"Cancers (Basel)"},{"key":"4547_CR30","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12915-014-0082-4","volume":"12","author":"A Luengo","year":"2014","unstructured":"Luengo A, Sullivan LB, Heiden MGV (2014) Understanding the complex-I-ty of metformin action: limiting mitochondrial respiration to improve cancer therapy. BMC Biol 12:82. https:\/\/doi.org\/10.1186\/s12915-014-0082-4","journal-title":"BMC Biol"},{"key":"4547_CR31","doi-asserted-by":"publisher","first-page":"6525","DOI":"10.1038\/sj.onc.1208812","volume":"24","author":"HL Lung","year":"2005","unstructured":"Lung HL, Bangarusamy DK, Xie D et al (2005) THY1 is a candidate tumour suppressor gene with decreased expression in metastatic nasopharyngeal carcinoma. Oncogene 24:6525\u20136532. https:\/\/doi.org\/10.1038\/sj.onc.1208812","journal-title":"Oncogene"},{"key":"4547_CR32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13046-022-02283-8","volume":"41","author":"S Mancarella","year":"2022","unstructured":"Mancarella S, Serino G, Gigante I et al (2022) CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype. J Exp Clin Cancer Res 41:65. https:\/\/doi.org\/10.1186\/s13046-022-02283-8","journal-title":"J Exp Clin Cancer Res"},{"key":"4547_CR33","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.devcel.2015.10.002","volume":"35","author":"DQ Matus","year":"2015","unstructured":"Matus DQ, Lohmer LL, Kelley LC et al (2015) Invasive cell fate requires G1 cell-cycle arrest and histone deacetylase-mediated changes in gene expression. Dev Cell 35:162. https:\/\/doi.org\/10.1016\/j.devcel.2015.10.002","journal-title":"Dev Cell"},{"key":"4547_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00030","author":"T Meng","year":"2019","unstructured":"Meng T, Jin J, Jiang C et al (2019) Molecular targeted therapy in the treatment of chordoma: a systematic review. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2019.00030","journal-title":"Front Oncol"},{"key":"4547_CR35","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1158\/2159-8290.CD-13-1030","volume":"4","author":"MJ Niederst","year":"2014","unstructured":"Niederst MJ, Benes CH (2014) EMT twists the road to PI3K. Cancer Discov 4:149\u2013151. https:\/\/doi.org\/10.1158\/2159-8290.CD-13-1030","journal-title":"Cancer Discov"},{"key":"4547_CR36","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3892\/ijo.2017.4206","volume":"52","author":"A Olejniczak","year":"2018","unstructured":"Olejniczak A, Szary\u0144ska M, Kmie\u0107 Z (2018) In vitro characterization of spheres derived from colorectal cancer cell lines. Int J Oncol 52:599\u2013612. https:\/\/doi.org\/10.3892\/ijo.2017.4206","journal-title":"Int J Oncol"},{"key":"4547_CR37","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1038\/s41467-019-10100-8","volume":"10","author":"V Prakash","year":"2019","unstructured":"Prakash V, Carson BB, Feenstra JM et al (2019) Ribosome biogenesis during cell cycle arrest fuels EMT in development and disease. Nat Commun 10:2110. https:\/\/doi.org\/10.1038\/s41467-019-10100-8","journal-title":"Nat Commun"},{"key":"4547_CR38","doi-asserted-by":"publisher","DOI":"10.5137\/1019-5149.JTN.1776-09.3","author":"H Sabuncuoglu","year":"2010","unstructured":"Sabuncuoglu H, Ozdogan S, Dogan H et al (2010) Total resection of inferiorly located sacral chordoma with posterior only approach: case report and review of the literature. Turk Neurosurg. https:\/\/doi.org\/10.5137\/1019-5149.JTN.1776-09.3","journal-title":"Turk Neurosurg"},{"key":"4547_CR39","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3171\/2017.7.SPINE17668","volume":"28","author":"R Sahyouni","year":"2018","unstructured":"Sahyouni R, Goshtasbi K, Mahmoodi A, Chen JW (2018) A historical recount of chordoma. J Neurosurg Spine 28:422\u2013428. https:\/\/doi.org\/10.3171\/2017.7.SPINE17668","journal-title":"J Neurosurg Spine"},{"key":"4547_CR40","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-14-0284","author":"B Salani","year":"2014","unstructured":"Salani B, Rio AD, Marini C et al (2014) Metformin, cancer and glucose metabolism. Endocr Relat Cancer. https:\/\/doi.org\/10.1530\/ERC-14-0284","journal-title":"Endocr Relat Cancer"},{"key":"4547_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2019.00066","volume":"7","author":"C Sauzay","year":"2019","unstructured":"Sauzay C, Voutetakis K, Chatziioannou A et al (2019) CD90\/Thy-1, a cancer-associated cell surface signaling molecule. Front Cell Dev Biol 7:66. https:\/\/doi.org\/10.3389\/fcell.2019.00066","journal-title":"Front Cell Dev Biol"},{"key":"4547_CR42","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","volume":"14","author":"T Shibue","year":"2017","unstructured":"Shibue T, Weinberg RA (2017) EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nat Rev Clin Oncol 14:611\u2013629. https:\/\/doi.org\/10.1038\/nrclinonc.2017.44","journal-title":"Nat Rev Clin Oncol"},{"key":"4547_CR43","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41374-020-0373-z","volume":"100","author":"M Sisto","year":"2020","unstructured":"Sisto M, Lorusso L, Ingravallo G et al (2020) TGF\u03b21-Smad canonical and -Erk noncanonical pathways participate in interleukin-17-induced epithelial\u2013mesenchymal transition in Sj\u00f6gren\u2019s syndrome. Lab Invest 100:824\u2013836. https:\/\/doi.org\/10.1038\/s41374-020-0373-z","journal-title":"Lab Invest"},{"key":"4547_CR44","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1002\/cncr.28032","volume":"119","author":"NR Smoll","year":"2013","unstructured":"Smoll NR, Gautschi OP, Radovanovic I et al (2013) Incidence and relative survival of chordomas. Cancer 119:2029\u20132037. https:\/\/doi.org\/10.1002\/cncr.28032","journal-title":"Cancer"},{"key":"4547_CR45","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1093\/annonc\/mdx054","volume":"28","author":"S Stacchiotti","year":"2017","unstructured":"Stacchiotti S, Gronchi A, Fossati P et al (2017) Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group. Ann Oncol 28:1230\u20131242. https:\/\/doi.org\/10.1093\/annonc\/mdx054","journal-title":"Ann Oncol"},{"key":"4547_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076830","volume":"8","author":"CHC Sukowati","year":"2013","unstructured":"Sukowati CHC, Anfuso B, Torre G et al (2013) The expression of CD90\/Thy-1 in hepatocellular carcinoma: an in vivo and in vitro study. PLoS ONE 8:e76830. https:\/\/doi.org\/10.1371\/journal.pone.0076830","journal-title":"PLoS ONE"},{"key":"4547_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111411","volume":"40","author":"K Takahashi","year":"2022","unstructured":"Takahashi K, Podyma-Inoue KA, Saito M et al (2022) TGF-\u03b2 generates a population of cancer cells residing in G1 phase with high motility and metastatic potential via KRTAP2-3. Cell Rep 40:111411. https:\/\/doi.org\/10.1016\/j.celrep.2022.111411","journal-title":"Cell Rep"},{"key":"4547_CR48","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1097\/00007632-199011010-00024","volume":"15","author":"K Tomita","year":"1990","unstructured":"Tomita K, Tsuchiya H (1990) Total sacrectomy and reconstruction for huge sacral tumors. Spine 15:1223","journal-title":"Spine"},{"key":"4547_CR49","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/neuros\/nyaa398","volume":"88","author":"JI Traylor","year":"2020","unstructured":"Traylor JI, Sheppard HE, Ravikumar V et al (2020) Computational drug repositioning identifies potentially active therapies for chordoma. Neurosurgery 88:428\u2013436. https:\/\/doi.org\/10.1093\/neuros\/nyaa398","journal-title":"Neurosurgery"},{"key":"4547_CR50","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.yexcr.2019.03.039","volume":"380","author":"EC Tuysuz","year":"2019","unstructured":"Tuysuz EC, Gulluoglu S, Yaltirik CK et al (2019) Distinctive role of dysregulated miRNAs in chordoma cancer stem-like cell maintenance. Exp Cell Res 380:9\u201319. https:\/\/doi.org\/10.1016\/j.yexcr.2019.03.039","journal-title":"Exp Cell Res"},{"key":"4547_CR51","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1101\/gad.294104","volume":"18","author":"S Vega","year":"2004","unstructured":"Vega S, Morales AV, Oca\u00f1a OH et al (2004) Snail blocks the cell cycle and confers resistance to cell death. Genes Dev 18:1131\u20131143. https:\/\/doi.org\/10.1101\/gad.294104","journal-title":"Genes Dev"},{"key":"4547_CR52","doi-asserted-by":"publisher","first-page":"610","DOI":"10.21037\/jtd.2017.03.28","volume":"9","author":"Y Wang","year":"2017","unstructured":"Wang Y, Zhang C, Zhu H et al (2017) CD90 positive cells exhibit aggressive radioresistance in esophageal squamous cell carcinoma. J Thorac Dis 9:610\u2013620. https:\/\/doi.org\/10.21037\/jtd.2017.03.28","journal-title":"J Thorac Dis"},{"key":"4547_CR53","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1002\/hep.22193","volume":"47","author":"RG Wells","year":"2008","unstructured":"Wells RG (2008) The role of matrix stiffness in regulating cell behavior. Hepatology 47:1394\u20131400. https:\/\/doi.org\/10.1002\/hep.22193","journal-title":"Hepatology"},{"key":"4547_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.104722","volume":"109","author":"D Wu","year":"2021","unstructured":"Wu D, Jia H, Zhang Z, Li S (2021) STAT3-induced HLA-F-AS1 promotes cell proliferation and stemness characteristics in triple negative breast cancer cells by upregulating TRABD. Bioorg Chem 109:104722. https:\/\/doi.org\/10.1016\/j.bioorg.2021.104722","journal-title":"Bioorg Chem"},{"key":"4547_CR55","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.3892\/or.2013.2784","volume":"30","author":"X Yan","year":"2013","unstructured":"Yan X, Luo H, Zhou X et al (2013) Identification of CD90 as a marker for lung cancer stem cells in A549 and H446 cell lines. Oncol Rep 30:2733\u20132740. https:\/\/doi.org\/10.3892\/or.2013.2784","journal-title":"Oncol Rep"},{"key":"4547_CR56","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s44194-022-00017-8","volume":"2","author":"X Yang","year":"2023","unstructured":"Yang X, Li P, Kang Z, Li W (2023) Targeted therapy, immunotherapy, and chemotherapy for chordoma. Curr Med 2:3. https:\/\/doi.org\/10.1007\/s44194-022-00017-8","journal-title":"Curr Med"},{"key":"4547_CR57","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s10020-023-00616-7","volume":"29","author":"F Zeng","year":"2023","unstructured":"Zeng F, Gao M, Liao S et al (2023) Role and mechanism of CD90+ fibroblasts in inflammatory diseases and malignant tumors. Mol Med 29:20. https:\/\/doi.org\/10.1186\/s10020-023-00616-7","journal-title":"Mol Med"},{"key":"4547_CR58","doi-asserted-by":"publisher","first-page":"946","DOI":"10.3892\/ijmm.2017.3314","volume":"41","author":"K Zhang","year":"2018","unstructured":"Zhang K, Che S, Su Z et al (2018) CD90 promotes cell migration, viability and sphere-forming ability of hepatocellular carcinoma cells. Int J Mol Med 41:946\u2013954. https:\/\/doi.org\/10.3892\/ijmm.2017.3314","journal-title":"Int J Mol Med"},{"key":"4547_CR59","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41420-025-02294-2","volume":"11","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Zhao S, Lv X et al (2025) CRAT downregulation promotes ovarian cancer progression by facilitating mitochondrial metabolism through decreasing the acetylation of PGC-1\u03b1. Cell Death Discov 11:15. https:\/\/doi.org\/10.1038\/s41420-025-02294-2","journal-title":"Cell Death Discov"},{"key":"4547_CR60","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1007\/s11033-019-04772-0","volume":"46","author":"X-W Zhao","year":"2019","unstructured":"Zhao X-W, Zhou J-P, Bi Y-L et al (2019) The role of MAPK signaling pathway in formation of EMT in oral squamous carcinoma cells induced by TNF-\u03b1. Mol Biol Rep 46:3149\u20133156. https:\/\/doi.org\/10.1007\/s11033-019-04772-0","journal-title":"Mol Biol Rep"},{"key":"4547_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1029670","volume":"12","author":"C Zhao","year":"2022","unstructured":"Zhao C, Tan T, Zhang E et al (2022) A chronicle review of new techniques that facilitate the understanding and development of optimal individualized therapeutic strategies for chordoma. Front Oncol 12:1029670. https:\/\/doi.org\/10.3389\/fonc.2022.1029670","journal-title":"Front Oncol"},{"key":"4547_CR62","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.3892\/or.2015.4243","volume":"34","author":"GC Zhu","year":"2015","unstructured":"Zhu GC, Gao L, He J et al (2015) CD90 is upregulated in gastric cancer tissues and inhibits gastric cancer cell apoptosis by modulating the expression level of SPARC protein. Oncol Rep 34:2497\u20132506. https:\/\/doi.org\/10.3892\/or.2015.4243","journal-title":"Oncol Rep"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04547-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04547-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04547-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T07:48:14Z","timestamp":1770882494000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04547-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["4547"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04547-4","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}